- Home
- Dermatology
- New-onset Systemic Lupus Erythematosus on Risankizumab for Psoriasis: A Case Report

20223 min read
Medical Article
Systemic lupus erythematosus (SLE) and psoriasis are both chronic immune-mediated illnesses, with SLE being caused by Th1, Th2, Th17, and B-cell activation and psoriasis being caused predominantly by Th17 activation (1). It has been noted that psoriasis and LE can coexist, however, this is uncommon. Drug-induced lupus (DIL) is a well-known occurren

New-onset Systemic Lupus Erythematosus on Risankizumab for Psoriasis: A Case Report
722 Reached
Similar Content

Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments

Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes

Rubella Syndrome in Neonate
1398 Reached12 Comments9 Likes

Black Lesion in Old Female
1972 Reached5 Comments11 Likes

Chronic Hyperplastic Candidiasis Of The Oral Mucosa
857 Reached9 Comments11 Likes